It said the new coverage would include assisted reproductive technology (ART) techniques and also cover labor analgesia to ease pain in childbirth. The most commonly performed ART procedure is in vitro fertilization (IVF).
The administration described China’s falling population as one of the biggest obstacles to national development and stressed it had already added ovulation-inducing drugs to its coverage, to help “reduce the burden of infertility.”
The expanded coverage is part of a wider attempt by Chinese authorities to persuade more people to get married and have more children.
The country’s population fell to 1.411 billion in 2022, a drop of 850,000 people from the previous year, according to China’s National Bureau of Statistics (NBS).
At the same time, the birthrate fell to a record low of 6.77 births per 1,000 people. Some 9.56 million babies were born in 2022, compared with 10.62 million in 2021.
China has 539 ART-approved medical institutions and 27 sperm banks as of June 2021, and each year these facilities facilitate more than one million IVF cycles, according to experts from the country’s National Clinical Research Center for Obstetrics and Gynecology.
Policymakers are increasingly concerned about the impact China’s growing demographic crisis could have on economic growth.
China introduced a highly controversial “one child” policy decades ago in an attempt to address fears of overpopulation and alleviate poverty, but decided to scrap it in 2015 amid concerns a rapidly aging population and shrinking workforce could threaten economic and social stability.
Chinese authorities are also moving to drop restrictions on…
Click Here to Read the Full Original Article at CNN.com – RSS Channel – HP Hero…